UPDATE 1-U.S. senator reveals results of opioid inquiry into Insys

BOSTON, Sept 6 (Reuters) - Insys Therapeutics Inc sought to manipulate insurance payment approval for an opioid cancer pain drug called Subsys even if for inappropriate uses, according to a U.S. Senate report on the opioid crisis released on Wednesday.